Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6456-6462, Vol. 69, No. 10
Department of Internal Medicine, Yale
University School of Medicine, New Haven, Connecticut 06520
Received 30 March 2001/Returned for modification 11 May
2001/Accepted 26 June 2001
Natural antibodies are those immunoglobulin molecules found in
mammalian serum that arise in the absence of exposure to environmental pathogens and may comprise an early host defense against invading pathogens. The spirochete Borrelia burgdorferi first
encounters natural antibodies when its arthropod vector, Ixodes
scapularis, begins feeding on a mammalian host. Natural
antibodies may therefore have an impact on pathogens within
blood-sucking vectors, prior to pathogen transmission to the mammal. In
this study, we investigated whether natural antibodies influenced the
number and/or phenotype of B. burgdorferi organisms
within feeding I. scapularis nymphs. Using a competitive
PCR, we found that ticks ingesting a blood meal from B-cell-deficient
mice, which lack all immunoglobulins, contained fivefold more
spirochete DNA than ticks feeding on control mice. Spirochete DNA
levels could be reduced to that of controls with passive transfer of
normal mouse serum or polyclonal immunoglobulin M (IgM), but not IgG,
into B-cell-deficient mice prior to placement of infected ticks. At
48 h of tick feeding, 90% of spirochetes within salivary glands
of ticks removed from B-cell-deficient mice were found by confocal
immunofluorescence microscopy to express outer surface protein A
(OspA), compared to only 5% of salivary gland spirochetes from ticks
detached from control mice. Taken together, these results show that
ingestion of natural antibodies limits the spirochete burden within
feeding ticks. Because OspA is normally downregulated when spirochetes
moved from the tick midgut to the salivary gland, our findings suggest
that OspA-expressing midgut spirochetes may be particularly susceptible
to the borrelicidal effects of these molecules.
Lyme disease, which is caused by
infection with the spirochete Borrelia burgdorferi, is a
vector-borne illness acquired through the bite of some
Ixodes ticks (2, 34, 36, 37). The duration of
tick attachment to the vertebrate host determines whether spirochetes are successfully transmitted, with the infection risk being greatest after 48 h (33, 35). After tick attachment,
spirochetes previously localized to the midgut multiply exponentially
and migrate to the salivary gland, where they exit the tick through
salivary secretions (8, 25, 27). Spirochete growth is
accompanied by marked phenotypic changes in outer surface protein (Osp)
expression. In particular, spirochetes modulate expression of OspA
(8, 31), a surface lipoprotein that has been reported to
mediate spirochete binding to the tick midgut (24).
Spirochetes in the midguts of unfed ticks uniformly express OspA, and
replicating spirochetes in the midguts of feeding ticks are a mixed
OspA+ and OspA One of the first immune components encountered by spirochetes within
the midguts of ticks feeding on naive hosts are natural antibodies.
Natural antibodies are germ line-encoded molecules produced by a
distinct population of peritoneal B cells bearing the cell surface
marker CD5 and are present in the sera and interstitial fluids of
healthy animals (14, 16, 17). The majority of natural
antibodies are immunoglobulin M (IgM) isotype; are polyreactive, with
various affinities for multiple antigens, including pathogens and
toxins (5, 22); and are present even in the absence of exposure to environmental pathogens (6, 17). Although
their contribution to immune defense has only recently been
appreciated, at concentrations present in serum, natural antibodies are
able to kill bacteria in vitro (22) and help clear
lipopolysaccharides in vivo (21, 26). They also facilitate
uptake, processing, and presentation of antigen by B cells (5,
38) and may help localize pathogens and their antigens to
lymphoid organs (14, 16, 22). B-cell-deficient mice, which
lack natural antibodies, have an increased pathogen burden in
nonlymphoid organs when infected with viruses or intracellular bacteria
compared to wild-type mice (22). Taken together, these
findings suggest a role for natural antibodies in limiting the initial
pathogen burden prior to the development of adaptive immune responses
(22).
Indirect evidence suggests that natural antibodies could contribute to
the host defense against B. burgdorferi infection. It has
been shown that IgM specifically interacts with OspA present in in
vitro spirochete cultures (11, 41). Sera from several species of nonimmune animals, which contain natural antibodies, can
kill spirochetes in vitro, and the killing is complement dependent (18). In this study, we postulated that ingestion of
natural antibodies during tick feeding could influence survival of
spirochetes within an infected tick, before their deposition within the
mammal. Because OspA is a dominant antigen on cultured spirochetes as well as those in the tick midgut where they first encounter natural antibodies, those spirochetes within the tick midgut may be
particularly susceptible to the effects of natural antibodies. To
investigate these issues, we compared the prevalence of OspA-expressing
spirochetes in the salivary glands as well as the total spirochete
burden within ticks that fed on B-cell-deficient and normal mice. Our results implicate natural antibodies of the IgM class in limiting survival of spirochetes in feeding ticks.
Mice.
Six-week-old C57BL/6J (B6) and B-cell-deficient
B6.129S2-Igh Tick infection.
Nymphal ticks infected with the pathogenic
B. burgdorferi N40 strain (20) were derived
from a specific-pathogen-free laboratory-reared colony of Ixodes
scapularis ticks maintained at the Department of Epidemiology and
Public Health at Yale University. Larval ticks were infected by feeding
on mice inoculated intradermally 1 month previously with
104 cultured N40 organisms. After feeding to
repletion and detaching naturally, engorged larvae were retrieved and
housed in 22°C humidified environmental chambers until they molted
into nymphs. The rate of infection of nymphs was 80 to 90% as assessed
by direct immunofluorescence of spirochetes in midgut extracts of
representative ticks.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6456-6462.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Natural Antibody Affects Survival of the Spirochete
Borrelia burgdorferi within Feeding Ticks
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
population, whereas the majority of those in the salivary glands of
feeding ticks no longer express this protein (7, 23). After deposition within the mammal, lipoproteins can activate innate
immune cells through pattern recognition receptors and induce
inflammation (3, 15). Thus, spirochete modulation of
surface lipoprotein expression may serve several purposes, including
facilitating migration within the tick and transmission to the
vertebrate host as well as evasion of the host innate immune response.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
(B6.Igh
/
) mice were purchased from Jackson
Laboratories. Mice were housed in filter frame cages and administered
food and water ad libitum according to Yale University animal care and
use guidelines. Mice were euthanized by carbon dioxide asphyxiation.
Passive immunization of mice. Mouse serum IgG and mouse monoclonal IgM (mIgM) (kappa clone TEPC 183, which recognizes an unidentified mouse tumor antigen) were purchased from Sigma Chemical Co. (St. Louis, Mo.). Polyclonal IgM (pIgM) was generated by depleting IgG from B6 mouse serum using the monoclonal antibody (MAb) Trap II kit according to the instructions of the manufacturer (Amersham-Pharmacia Biotech, Piscataway, N.J.). Briefly, whole normal mouse serum (NMS) diluted 1:3 in phosphate-buffered saline (PBS) was passed over a HiTrap protein G column twice, and the eluant was collected. The IgG-depleted eluant was buffer exchanged into PBS and concentrated using a Centriprep p-30 column (Amicon, Bedford, Mass.). The IgM and IgG concentrations were determined by Ig isotype-specific enzyme-linked immunosorbent assay using biotinylated secondary antibodies and the Vectastain Elite and ABTS [2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid)] kits (Vector Laboratories, Burlingame, Calif.) according to the manufacturer's protocols. The NMS used in these experiments contained 1.4 mg of IgG per ml and 1.1 mg of IgM per ml, and pIgM contained 0.2 mg of IgM per ml and 0.003 mg of IgG per ml.
Groups of three or four mice were passively immunized by subcutaneous injection with PBS alone or PBS containing 50 µl of NMS or 50 µg of Ig (IgG, mIgM, or pIgM) in a total volume of 500 µl daily for 2 days prior to tick placement. On the day of tick placement, the Ig and NMS doses in PBS were doubled but were still delivered in the same total volume.Salivary gland microscopy. The salivary glands from individual nymphs were harvested under a dissecting microscope and fixed by immersion in 50 µl of 4% formaldehyde in PBS on silylated glass slides (PGC Scientific, Gaithersburg, Md.) for 1 h at room temperature. Tissues were rinsed twice with PBS, permeabilized by incubation in 0.5% Triton X-100 in PBS for 15 min at room temperature, and then blocked for 1 h at room temperature or overnight at 4°C in PBS containing 10% normal goat serum. For immunofluorescent staining, fixed and permeabilized salivary glands were incubated for 1 h with B-cell hybridoma supernatant containing anti-OspA MAb VIIIC3.78 (32) diluted 1:75 in PBS-10% normal goat serum. The organs were washed three times with PBS and then incubated for 1 h with fluorescein isothiocyanate (FITC)-conjugated goat anti-B. burgdorferi IgG (1:50 dilution) (KPL, Gaithersburg, Md.) and Texas red-conjugated anti-mouse IgG (1:100 dilution) (Tago, Burlingame, Calif.). After extensive washing, stained organs were air dried and mounted onto glass slides using Gel/Mount (Biomeda Corp., Foster City, Calif.). Samples were imaged using an LSM 510 scanning laser confocal microscope equipped with an argon-krypton laser (Carl Zeiss Inc., Thornwood, N.Y.). The salivary glands were visualized using the confocal microscope 63× objective, and the section depth was 0.6 µm.
Competitive PCR of B. burgdorferi DNA. Whole ticks were ground in Eppendorf tubes using disposable plastic pestles, and the DNA was extracted using the Isoquick DNA isolation kit (Orca Research Inc., Bothwell, Wash.). The DNA samples were resuspended in 50 µl of water. The relative amount of B. burgdorferi DNA in each sample was determined using a competitive PCR targeting a B. burgdorferi-specific fragment of the chromosomal glyceraldehyde-3-phosphate dehydrogenase gene (termed Bb-GAPDH). Based on GenBank data, the B. burgdorferi GAPDH gene has homology only to that of a related spirochete, Borrelia hermsii, the agent of relapsing fever (13). The Bb-GAPDH primers used were as follows: 5' primer 5'AGTCAAGAGATGGTGCCATTGTTGTGG3' (bp 319 to 345) and 3' primer 5'GTACCATTCAACTTACCCTTAAGTTCGG3' (bp 817 to 844). The competitor gene target was generated by cloning the full-length GAPDH gene into plasmid pGEX-5x-2 (Amersham-Pharmacia Biotech) and excising bp 402 to 471. Amplification of the competitor gene using the Bb-GAPDH primers results in a 456-bp product, which is 69 bp smaller than that amplified from the native gene (525 bp). One microliter of tick DNA was amplified in a 50-µl total volume containing 25 µM primers, 1.6 mM deoxynucleoside triphosphates (Boehringer Mannheim, Indianapolis, Ind.), 2.75 mM MgCl2, and 0.5 µl of Taq polymerase (Qiagen, Valencia, Calif.) using a Robocycler (Stratagene, La Jolla, Calif.) with the following settings: denaturation at 95°C for 90 s, annealing at 56°C for 60 s, and extension at 73°C for 75 s for a total of 40 cycles. Titrations of known quantities of the competitor plasmid were added to each reaction mixture, and the relative amount of spirochete DNA in each sample was determined from the quantity of competitor added to each PCR that resulted in equivalent amplification of competitor and Bb-GAPDH target gene sequences. This competitive assay was validated using DNA from known titrating quantities of cultured B. burgdorferi (data not shown). Bb-GAPDH PCR products were normalized to the amount of tick actin amplified from each sample. A 400-bp fragment of actin was amplified from 1 and 0.25 µl of sample DNA using the following arthropod actin-specific primers: 5' primer 5'GCCGATGGTGATCACCTGTCCG3' and 3' primer 5'GATGACCCAGATCATGTTCGAGCC3'. Reaction conditions were similar to those used for Bb-GAPDH, and the thermocycler settings were as follows: denaturation at 95°C for 90 s, annealing at 59°C for 60 s, and extension at 73°C for 75 s for a total of 36 cycles.
In vitro borrelicidal assay. Low-passage N40 spirochetes were grown to logarithmic phase in Barbour-Stoenner-Kelley (BSK) II medium (1) and then washed and resuspended at a final concentration of 107 spirochetes per ml in PBS supplemented with 5.4 mM glucose, 50% heat-inactivated rabbit serum, and A 1956, an antibiotic mixture designed for Borrelia culture (Sigma). Spirochetes remain viable but do not divide in this solution. Spirochetes (2 × 106/200 µl) were aliquoted in triplicate into screw-top Eppendorf tubes containing the indicated dilution of MAb or serum (see Table 1) and 10 µl of mouse complement (1 50% hemolytic complement unit/ml; Sigma). The final amounts of Igs in the samples were as follows: (i) for MAb VIIIC3.78, 0.16 µg of IgG; (ii) for B6 14-day immune serum, 12.8 µg of IgG and 8.8 µg of IgM; and (iii) for B6 naive serum, 11.6 µg of IgG and 8.8 µg of IgM. After 24 h of incubation at 33°C, samples were examined by dark-field microscopy for viable spirochetes in a double-blind fashion. Spirochetes were considered dead when complete loss of motility and refractivity was observed. Spirochetes were enumerated in 10 visual fields, and the percent viability was calculated as the ratio of live spirochetes (mean of 10 fields) in treated samples to spirochetes in the untreated control samples (mean of 10 fields). Serum from 14-day B. burgdorferi-infected B6 mice and the borrelicidal MAb VIIIC3.78 were used as positive controls for killing. In addition, from the third experiment, a 50-µl aliquot of spirochetes from each tube was inoculated into 0.5 ml of BSK II medium and incubated at 33°C for 48 h. The viable spirochetes in the cultures were enumerated, and percent viability was calculated as described above.
| |
RESULTS |
|---|
|
|
|---|
Natural IgM antibody can kill spirochetes in vitro.
Previous
studies have shown that IgM can bind to cultured spirochete Osps
(11) and that serum from nonimmune mammals can kill
spirochetes in vitro (18). To determine whether natural antibodies could account for the borrelicidal activity, we compared the
viabilities of spirochetes cultured in the presence or absence of
natural antibody using serum from control B6 mice or serum from
B-cell-deficient mice (B6.Igh
/
), which do not
produce antibody (Table 1). In this
assay, spirochetes were readily killed by the borrelicidal anti-OspA
MAb and serum from 14-day-infected B6 mice (Table 1). In addition,
naive B6 serum was borrelicidal, albeit with reduced efficiency
compared to immune sera. In contrast, serum from
B6.Igh
/
mice had no effect on spirochete
survival. Addition of pIgM to B6.Igh
/
serum
restored the killing capacity of this serum, but addition of IgG had
only a minimal effect. Based on the number of remaining viable
spirochetes, the killing capacities of only the OspA MAb, immune serum,
naive serum, and B6 Igh
/
serum supplemented
with pIgM were found to be statistically different from that of the PBS
negative control (P < 0.01 using Dunnett's multiple-comparison test). Spirochetes cultured with pIgM without B6.Igh
/
serum and complement were not killed,
indicating that pIgM did not contain significant levels of complement
or other non-Ig serum components with potential borrelicidal activity
(data not shown). Aliquots of spirochetes from the third experiment
were cultured in BSK II medium for 2 days. Enumeration of the
spirochetes at this time point confirmed the results obtained from the
borrelicidal assay, with similar relative differences in the
percentages of viable spirochetes among the samples.
|
Spirochetes that migrate to the salivary glands of ticks that feed
on B6.Igh
/
mice express OspA.
Previous studies
have shown that the majority of spirochetes within the salivary glands
of feeding ticks no longer express OspA (7, 9). Our
findings that serum containing pIgM can kill OspA-expressing
spirochetes in vitro suggested that natural antibodies could influence
survival of OspA-expressing spirochetes within feeding ticks. Natural
antibodies that bind to OspA-expressing spirochetes in the midgut may
promote their elimination in the gut or hemolymph, preventing them from
reaching the salivary glands. We therefore sought to determine whether
natural antibody influences the percentage of OspA-expressing
spirochetes in the salivary glands of feeding ticks. Forty-eight hours
after feeding on B6.Igh
/
or control mice,
ticks were removed and the spirochetes within salivary glands were
visualized by confocal immunofluorescence microscopy. Using two-color
staining, this technology permits simultaneous identification of
spirochetes with anti-B. burgdorferi antibodies and
assessment of their OspA expression within the thick tissue of the
salivary gland. As previously reported, OspA+
spirochetes were only rarely detected in salivary glands of ticks that
fed on control B6 mice (Fig.
1, WT).
In contrast, examination of multiple salivary glands from ticks that
fed on B6.Igh
/
mice revealed that almost all
spirochetes could be visualized using the OspA MAb (Fig. 1, PBS).
|
Natural IgM but not IgG decreases the prevalence of
OspA+ spirochetes in salivary glands of ticks feeding on
B6.Igh
/
mice.
We next passively immunized
B6.Igh
/
mice with NMS, pIgM, mIgM, IgG, or
PBS prior to tick placement in order to assess which component of
natural antibody, if any, influenced the presence of
OspA+ spirochetes in the salivary gland. At
48 h of feeding, ticks that fed on IgG- or mIgM-immunized
B6.Igh
/
mice had predominantly
OspA+ spirochetes within their salivary glands
(Fig. 1). However, OspA+ spirochetes were rarely
seen in the salivary glands of ticks feeding on NMS-immunized or
pIgM-immunized B6.Igh
/
mice, similar to what
was observed in ticks feeding on B6 control mice (Fig. 1). The number
of spirochetes per gland was relatively small at the 48-h time point,
even when ticks fed upon B6.Igh
/
mice. In
order to determine the percentages of OspA-expressing spirochetes in
the salivary glands, we analyzed and counted the total number of
spirochetes in four to six glands from each experimental group by
confocal microscopy (Table 2). The
greatest percentages of spirochetes that express OspA in salivary
glands were found in ticks that fed on
B6.Igh
/
mice treated with PBS alone, mIgM, or
IgG (Table 2). In contrast, OspA was found on fewer than 10% of the
spirochetes in salivary glands from ticks that fed on
B6.Igh
/
mice treated with NMS or pIgM and in
salivary glands from ticks that fed on normal B6 mice (Table 2).
|
OspA is not detected on spirochetes in tick salivary glands after
72 h of feeding, independent of antibody.
The mechanism by
which spirochetes diminish OspA expression within the tick has not been
clearly defined. However, there is no evidence showing that an
individual spirochete can regulate Osp expression at the molecular
level because of immune pressure. Thus, we expect that OspA expression
can still be modulated by spirochetes regardless of the host on which
the tick obtains its blood meal. Indeed, OspA-expressing spirochetes
were rarely observed in salivary glands of ticks that were allowed to
feed for 72 h, irrespective of the mouse host, with the
PBS-immunized B6.Igh
/
group having the
largest percentage remaining (Table 2).
Natural antibody reduces the total number of spirochetes within
feeding ticks.
Cultured B. burgdorferi strain N40
spirochetes express high levels of OspA (19) and therefore
are similar in phenotype to tick midgut spirochetes, which also express
OspA (9). We have shown that OspA-expressing spirochetes
are susceptible to the borrelicidal activity of natural IgM in vitro
and that there is a marked decrease in the number of OspA-expressing
spirochetes in salivary glands of ticks that fed on B6 mice as well as
in those that fed on B6.Igh
/
mice treated
with NMS or pIgM. Taken together, these data suggest that IgM natural
antibody may reduce the number of spirochetes replicating in the
midguts of feeding ticks, prior to their migration to the salivary
glands. We next used a competitive PCR to assess the relative number of
spirochetes in ticks that fed on B6.Igh
/
or
control mice. Whole ticks were used because spirochetes may be lost
during dissection of individual organs. A B. burgdorferi-specific fragment of the GAPDH gene was selected for
amplification because this target is present in a single copy on the
B. burgdorferi chromosome. Ticks were removed 72 h
after placement, and scutal indices were measured to ensure comparable
durations of feeding (12, 35). Compared to ticks that fed
on B6 mice, those that ingested a blood meal from
B6.Igh
/
mice harbored on average fivefold
more spirochete DNA (Table 3). Passive
transfer of IgG to B6.Igh
/
mice prior to tick
placement did not reduce the pathogen load in feeding ticks. In
contrast, ticks that fed on B6.Igh
/
mice
passively immunized with NMS or pIgM had levels of B. burgdorferi DNA equivalent to those of ticks retrieved from
control B6 mice (Table 3).
|
| |
DISCUSSION |
|---|
|
|
|---|
These studies provide evidence that natural antibody exerts an
effect on spirochete survival within feeding ticks. Using a competitive
PCR for spirochete DNA, we have shown that ticks feeding on
B6.Igh
/
mice harbor more spirochetes than
those feeding on normal B6 mice. While the absolute numbers of
spirochetes in unfed ticks are presumed to vary, we found a
reproducible increase in the pathogen burden among engorged ticks
removed from B6.Igh
/
mice compared to those
feeding on control mice. NMS can kill spirochetes in vitro, and we show
that natural antibody of the IgM class is required for the borrelicidal
activity both in vitro and in feeding ticks. Although it was not
analyzed in this study, we believe that this effect of natural
antibodies is preferentially exerted on spirochetes within the midgut,
as there is no evidence that host IgM, unlike host IgG, can penetrate
the hemolymph and enter the salivary gland (39).
OspA is a dominant surface-exposed lipoprotein on cultured N40
spirochetes (19) as well as those within the midguts of
unfed ticks (9). Previous studies have shown that
OspA+ spirochetes are rarely found within
salivary glands of ticks feeding on normal nonimmune hosts (7,
9). We show here that the majority of spirochetes within the
salivary glands of ticks feeding on B6.Igh
/
mice continue to express OspA at 48 h after tick attachment. In
one experiment, we observed OspA+ spirochetes at
as late as 64 h of tick feeding (data not shown). In fact, we
found that in the absence of natural antibody almost all salivary gland
spirochetes (90%) expressed OspA when ticks fed for 48 h,
compared to only 5% when ticks fed on normal mice. Other studies
confirm our observation that OspA+ spirochetes
can occasionally be found within the salivary glands of feeding ticks
removed from normal B6 mice, albeit at a much lower frequency
(23).
The absence of natural antibody, which we show can kill OspA-expressing spirochetes in vitro, may permit more OspA+ spirochetes to survive and reach the salivary glands. However, the majority of spirochetes after 72 h of tick feeding no longer express OspA, regardless of the presence of natural antibody in the host. For this reason, we do not believe that the immune pressure exerted by natural antibody directly influences expression of OspA or other surface-exposed Osps at the molecular level. Our studies did not address the molecular mechanisms by which the expression of OspA is controlled.
Our studies utilized MAb VIIIC3.78 to detect OspA on spirochetes. It is possible that natural antibody present in serum could mask the MAb binding site, obscuring the detection of OspA expression on salivary gland spirochetes. However, this would not seem to be a concern, as spirochetes are efficiently killed within ticks allowed to feed upon mice passively immunized with MAb VIIIC3.78 (10), indicating that this MAb can still access or compete for its binding site on OspA in the presence of natural antibodies.
OspA is reported to mediate binding of spirochetes to the tick midgut (24), and presumably that binding must be interrupted for spirochetes to leave the midgut. Our data quantifying OspA+ spirochetes in salivary glands show that complete downregulation of OspA is not necessary for spirochetes to leave the midgut and migrate to the salivary glands. In addition, OspA complexed with IgM has been found in patients with early Lyme disease, indicating that some spirochetes continue to express this antigen after transmission to the vertebrate host (4, 28-30). It may be that the tick midgut loses expression of the OspA ligand(s) during tick feeding, resulting in diminished spirochete binding independent of OspA expression.
pIgM, but not IgG, delivered to B6.Igh
/
mice
prior to tick placement diminishes the percentage of OspA-expressing
spirochetes within tick salivary glands to levels in ticks feeding on
normal hosts. The ability of antibody to fix complement may explain the differential effects of natural IgM and IgG in these assays. In addition, tick saliva contains IgG binding proteins that can sequester IgG, possibly to prevent damage to the tick, and spirochetes may indirectly benefit from this tick defense mechanism (40).
IgM may exert selective pressure on spirochetes such that those with reduced levels of surface-exposed Osps, including OspA, have much higher survival rates. This may explain the apparent reduced
infectivity of OspA+ spirochetes deposited within
host tissues during the early stages of tick feeding (23),
as those spirochetes that escaped midgut elimination will next
encounter IgM in the mammalian skin. Binding of IgM to OspA may also
expedite shedding of the protein from the surface of the spirochetes.
Our study did not examine OspA expression at the molecular level, and
OspA appears to be normally downregulated in the late stages of tick feeding.
In summary, this study shows that natural antibody of the IgM class has borrelicidal activity and can reduce spirochete numbers within feeding I. scapularis nymphs. Natural antibodies may therefore function as a first defense against B. burgdorferi and other vector-borne pathogens that have exposure to these molecules in the tick midgut prior to deposition within the vertebrate host.
| |
ACKNOWLEDGMENTS |
|---|
We thank Durland Fish (Yale University Department of Epidemiology and Public Health) for providing all the infected ticks for these experiments. We thank Deborah Beck for her assistance with all of the mouse studies, Denise Lusitani for her helpful advice, and Ruth Montgomery for critically evaluating the manuscript.
Maintenance of ticks at the Yale University Department of Epidemiology and Public Health is supported by USDA-ARS Cooperative Agreement no. 58-1265-7-002 and the G. Harold & Leila Y. Mathers Charitable Foundation. This work was supported by a grant from the National Institutes of Health (AR42637) to L.K.B. and by a postdoctoral fellowship from the Arthritis Foundation to A.A.B.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520. Phone: (203) 785-7063. Fax: (203) 785-7053. E-mail: linda.bockenstedt{at}yale.edu.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525[Medline]. |
| 2. | Bockenstedt, L. K., and S. E. Malawista. 1995. Lyme disease, p. 1234-1249. In R. R. Rich (ed.), Clinical immunology. Mosby-Year Book, St. Louis, Mo. |
| 3. |
Brightbill, H. D.,
D. H. Libraty,
S. R. Krutzik,
R.-B. Yang,
J. T. Belisle,
J. R. Bleharski,
M. Maitland,
M. V. Norgard,
S. E. Plevy,
S. T. Smale,
P. J. Brennan,
B. R. Bloom,
P. J. Godowski, and R. L. Modlin.
1999.
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Science
285:732-736 |
| 4. | Brunner, M. 2001. New method for detection of Borrelia burgdorferi antigen complexed to antibody in seronegative Lyme disease. J. Immunol. Methods 249:185-190[CrossRef][Medline]. |
| 5. | Carroll, M. C., and A. P. Prodeus. 1998. Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10:36-40[CrossRef][Medline]. |
| 6. | Casali, P., and E. W. Schettino. 1996. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. 210:167-179[Medline]. |
| 7. | de Silva, A. M., and E. Fikrig. 1997. Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol. Today 13:267-270[CrossRef][Medline]. |
| 8. | de Silva, A. M., and E. Fikrig. 1995. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am. J. Trop. Med. Hyg. 53:397-404. |
| 9. |
de Silva, A. M.,
S. R. Telford III,
L. R. Brunet,
S. W. Barthold, and E. Fikrig.
1996.
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
J. Exp. Med.
183:271-275 |
| 10. |
de Silva, A. M.,
N. S. Zeidner,
Y. Zhang,
M. C. Dolan,
J. Piesman, and E. Fikrig.
1999.
Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
Infect. Immun.
67:30-35 |
| 11. |
Dorward, D. W.,
E. D. Huguenel,
G. Davis, and C. F. Garon.
1992.
Interactions between extracellular Borrelia burgdorferi proteins and non-Borrelia-directed immunoglobulin M antibodies.
Infect. Immun.
60:838-844 |
| 12. |
Falco, R. C.,
D. Fish, and J. Piesman.
1996.
Duration of tick bites in a Lyme disease-endemic area.
Am. J. Epidemiol.
143:187-192 |
| 13. | Gebbia, J. A., P. B. Backenson, J. L. Coleman, P. Anda, and J. L. Benach. 1997. Glycolytic enzyme operon of Borrelia burgdorferi: characterization and evolutionary implications. Gene 188:221-228[CrossRef][Medline]. |
| 14. | Greenberg, A. H. 1985. Antibodies and natural immunity. Biomed. Pharmacother. 39:4-6[Medline]. |
| 15. |
Hirschfeld, M.,
C. J. Kirschning,
R. Schwander,
H. Wesche,
J. H. Weis,
R. M. Wooten, and J. J. Weis.
1999.
Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.
J. Immunol.
163:2382-2386 |
| 16. | Kasaian, M. T., and P. Casali. 1993. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity 15:315-329[Medline]. |
| 17. | Kasaian, M. T., H. Ikematsu, and P. Casali. 1992. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J. Immunol. 148:2690-2702[Abstract]. |
| 18. |
Kurtenbach, K.,
H. S. Sewell,
N. H. Ogden,
S. E. Randolph, and P. A. Nuttall.
1998.
Serum complement sensitivity as a key factor in Lyme disease ecology.
Infect. Immun.
66:1248-1251 |
| 19. |
Montgomery, R. B.,
S. E. Malawista,
K. J. M. Feen, and L. K. Bockenstedt.
1996.
Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
J. Exp. Med.
183:261-269 |
| 20. | Moody, K. D., S. W. Barthold, and G. A. Terwilliger. 1990. Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 43:87-92. |
| 21. | Moss, R. B., Y. P. Hsu, P. H. Van Eede, A. M. Van Leeuwen, N. J. Lewiston, and G. De Lange. 1987. Altered antibody isotype in cystic fibrosis: impaired natural antibody response to polysaccharide antigens. Pediatr. Res. 22:708-713[Medline]. |
| 22. |
Ochsenbein, A. F.,
T. Fehr,
C. Lutz,
M. Suter,
F. Brombacher,
H. Hengartner, and R. M. Zinkernagel.
1999.
Control of early viral and bacterial distribution and disease by natural antibodies.
Science
286:2156-2159 |
| 23. |
Ohnishi, J.,
J. Piesman, and A. M. de Silva.
2001.
Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Proc. Natl. Acad. Sci. USA
98:670-675 |
| 24. | Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet, and E. Fikrig. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Investig. 106:561-569[Medline]. |
| 25. | Piesman, J. 1995. Dispersal of the Lyme disease spirochete Borrelia burgdorferi to salivary glands of feeding nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol. 32:519-521[Medline]. |
| 26. | Reid, R. R., A. P. Prodeus, W. Khan, T. Hsu, F. S. Rosen, and M. C. Carroll. 1997. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 159:970-975[Abstract]. |
| 27. | Ribeiro, J. M., T. N. Mather, J. Piesman, and A. Spielman. 1987. Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks. J. Med. Entomol. 24:201-205[Medline]. |
| 28. | Schutzer, S. E., P. K. Coyle, J. J. Dunn, B. J. Luft, and M. Brunner. 1994. Early and specific antibody response to OspA in Lyme Disease. J. Clin. Investig. 94:454-457. |
| 29. | Schutzer, S. E., P. K. Coyle, L. B. Krupp, Z. Deng, A. L. Belman, R. Dattwyler, and B. J. Luft. 1997. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J. Clin. Investig. 100:763-767[Medline]. |
| 30. |
Schutzer, S. E.,
P. K. Coyle,
P. Reid, and B. Holland.
1999.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
JAMA
282:1942-1946 |
| 31. |
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913 |
| 32. | Sears, J., E. Fikrig, T. Nakagawa, K. Deponte, N. Marcantonio, F. Kantor, and R. A. Flavell. 1991. Molecular mapping of OspA-mediated protection against Borrelia burgdorferi, the Lyme disease agent. J. Immunol. 147:1995-2001[Abstract]. |
| 33. | Shih, C.-M., R. J. Pollack, S. R. Telford III, and A. Spielman. 1992. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice. J. Infect. Dis. 166:827-831[Medline]. |
| 34. | Sigal, L. H. 1997. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu. Rev. Immunol. 15:63-92[CrossRef][Medline]. |
| 35. | Sood, S. K., M. B. Salzman, B. J. B. Johnson, C. M. Happ, K. Feig, L. Carmody, L. G. Rubin, E. Hilton, and J. Piesman. 1997. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J. Infect. Dis. 175:996-999[Medline]. |
| 36. | Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 321:586-596[Abstract]. |
| 37. | Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-740[Abstract]. |
| 38. | Thornton, B. P., V. Vetvicka, and G. D. Ross. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727-1737[Abstract]. |
| 39. | Wang, H., and P. A. Nuttall. 1994. Excretion of host immunoglobulin in tick saliva and detection of IgG-binding proteins in tick haemolymph and salivary glands. Parasitology 109:525-530. (Erratum, 110:363, 1995.) |
| 40. | Wang, H., and P. A. Nuttall. 1995. Immunoglobulin G binding proteins in male Rhipicephalus appendiculatus ticks. Parasite Immunol. 17:517-524[Medline]. |
| 41. |
Whitmire, W. M., and C. F. Garon.
1993.
Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi.
Infect. Immun.
61:1460-1467 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|